N″-cyano-N-4-pyridyl-N′-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): A new, potent vasodilator
N″-cyano-N-4-pyridyl-N′-1,2,2-trimethylpropylguanidine, monohydrate (P 1134) is a new agent which induces a marked and sustained hypotensive response in normotensive and renal, neurogenic, and spontaneously hypertensive rats, as well as in normotensive and renal hypertensive dogs. The overall potency of this compound is 2–3 times greater than that of hydralazine. The fall of blood pressure is accompanied by an increase in heart rate and cardiac output and a decrease in total peripheral resistance. The hypotensive effect appears to be due primarily to a direct relaxant effect on vascular smooth muscle.
KeywordsCardiac Output Plasma Renin Activity Hydralazine Mean Arterial Blood Pressure Hypotensive Effect
Unable to display preview. Download preview PDF.
- 3.H.J. Petersen, German Patent offenleg. 2557438, 1976.Google Scholar
- 10.S. Mellander and R. Johansson, Pharmac. Rev.20, 117 (1968).Google Scholar
- 11.H. Brunner, P.R. Hedwall and M. Meier, Br. J. Pharmac.30, 123 (1967).Google Scholar
- 12.A.A. Rubin, L. Zitowitz and L. Hausler, J. Pharmac. exp. Ther.140, 46 (1963).Google Scholar
- 15.C. Carpi and L. Dorigotti Br. J. Pharmac.52, 459 (1974).Google Scholar
- 16.The (+)- and (−)-forms were obtained by fractionated crystallization of the D(−)- and (+)-tartrates, respectively, from 80% EtOH. [a]D20:+135° and −135° (c=1, EtOH).Google Scholar
- 17.T. Hilden, personal communication.Google Scholar